Last reviewed · How we verify
NCT04600349
Identity Oriented Psychotrauma Therapy on Hashimoto in Adults
NA trial testing Identity Oriented Psychotrauma Therapy in Autoimmune Thyroiditis in 70 participants. Completed in 1 March 2021.
30 December 2020
Quick facts
| Lead sponsor | University of Bucharest |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 70 |
| Start date | 1 February 2020 |
| Primary completion | 30 December 2020 |
| Estimated completion | 1 March 2021 |
| Sites | 1 location across Romania |
Drugs / interventions tested
- Identity Oriented Psychotrauma Therapy
- Treatment as Usual
Conditions studied
- Autoimmune Thyroiditis — all drugs for Autoimmune Thyroiditis →
Sponsor
University of Bucharest
Who can join
Adults 18 to 60, any sex, with Autoimmune Thyroiditis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate whether Identity Oriented Psychotrauma Therapy (IOPT) is effective in decreasing the level of autoantibodies of patients with Hashimoto thyroiditis. The investigators hypothesize that working Constellations of Intention will have a positive impact on the biological level, by decreasing the level of autoantibodies, antithyroglobulin antibody (anti-Tg) and anti-thyroid peroxidase antibody (anti-TPO), which are the main antibodies detected in chronic autoimmune thyroiditis. Secondly, it will have an impact on the psyche by decreasing the level of dissociation, alexithymia, anger, and by increasing the quality of life and than those in the control group.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Medical Applications of Molecular Biotechnologies in the Context of Hashimoto's Thyroiditis.
Trovato M, Valenti A. · · 2023 · cited 1× · PMID 37371008 · DOI 10.3390/diagnostics13122114 -
The influence of identity-oriented psychotrauma therapy on Hashimoto disease activity: a randomised controlled trial.
Macarenco MM, Opariuc-Dan C, Georgescu T. · · 2025 · PMID 40568843 · DOI 10.1080/20008066.2025.2520636
Verify or expand the search:
- PubMed search for NCT04600349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Bucharest trials
Trials by the same sponsor.
- NCT07069361 — Mindful Emotion Regulation in Organizational Contexts · NA · completed
- NCT06359769 — Group Cognitive Evolutionary Therapy for Depression · NA · active not recruiting
- NCT06883773 — Digital Rewards and Retention in a M-health App · NA · not yet recruiting
- NCT06271759 — Psychological Effects of a Set of Essential Oils · NA · recruiting
- NCT05249855 — Balneotherapy and Anxiety During SARS-CoV-2 Pandemic · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04600349 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Bucharest
- Last refreshed: 23 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04600349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing